1910 Genetics

About:

1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development.

Website: http://www.1910genetics.com

Twitter/X: 1910Genetics

Top Investors: Y Combinator, M12 - Microsoft's Venture Fund, FoundersX Ventures, Playground Global, Sam Altman

Description:

1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development. The company establishes an understanding of the molecular basis of disease to the granularity at which the world understands sickle cell anemia. This understanding drives their integration of artificial intelligence (AI), computation, and biological automation to accelerate the design of small molecule and protein therapeutics.

Total Funding Amount:

$26.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2018-05-01

Contact Email:

partnering(AT)1910genetics.com

Founders:

Jen Nwankwo

Number of Employees:

11-50

Last Funding Date:

2021-09-30

IPO Status:

Private

© 2024 MyAiNote.com